『Effective corticosteroid agent ‘Spolon Tablet’ launched』
KyungDong Pharm Co., Ltd. releases the adrenocorticosteroid drug ‘Spolon Tablet (methylprednisolone 4mg)’ on October 1, 2014.
‘Spolon tablets’ contain methylprednisolone, which is a methyl group introduced into prednisolone, and are a product that reduces adverse reactions such as edema and increased blood pressure due to sodium retention compared to prednisolone preparations.
It can be used for a very wide range of indications, including rheumatic disorders, collagen diseases, skin diseases, allergic diseases, and ophthalmic diseases, and is expected to be helpful in treating various diseases in most departments in the future.
♤ Product Information ♤
|
Product Name |
Spollon Jeong |
|
Ingredient content |
Methylprednisolone 4 mg |
|
Indications |
Endocrine disorders, rheumatic disorders, collagen diseases, skin diseases, Allergic diseases, eye diseases, gastrointestinal diseases, respiratory diseases, blood diseases, malignant neoplastic diseases, edematous diseases, nervous system diseases, etc. |
|
Dosage and usage |
Varies from 4-48mg per day. (Depends on symptoms of specific disease) |
|
Reimbursement Prices |
98 won/tablet |
|
Reimbursement Code |
648103410 |
|
Packaging unit |
30 tablets, 200 tablets |
※ Please refer to the product manual for other details such as precautions for use.